| Gemeprost versus misoprostol for cervical priming before first-trimester abortion: a randomized controlled trial. | |
| | |
MedLine Citation:
|
PMID: 12681876 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To compare the efficacy of 400 microg of misoprostol with that of 1 mg of gemeprost as cervical priming agents when administered vaginally 3 to 4 hours before first-trimester vacuum aspiration abortion. METHODS: In a prospective controlled trial 90 nulliparous women who requested termination of pregnancy before 12 weeks' gestation were randomized to receive vaginally either misoprostol or gemeprost for cervical priming. The force to dilate the cervix was measured by the use of a cervical tonometer connected to Hegar dilators from 3 to 10 mm. The main outcome measures were baseline cervical dilation; the peak force to dilate the cervix at 8, 9, and 10 mm; and the cumulative force to dilate the cervix to 10 mm. RESULTS: Baseline cervical dilation did not differ significantly between the women who received misoprostol and those who were treated with gemeprost. Neither the peak force required to dilate the cervix at 8, 9, and 10 mm nor the cumulative force to dilate the cervix to 10 mm showed any significant difference between the two groups. CONCLUSION: Vaginally administered misoprostol (400 microg) is as effective as gemeprost (1 mg) for cervical priming 3 to 4 hours before surgical termination of first-trimester pregnancies. |
| | |
Authors:
|
E Ekerhovd; N Radulovic; A Norström |
Related Documents
:
|
3828256 - Genital condylomata acuminata in pregnancy: effectiveness, safety and pregnancy outcome... 12365596 - Cervical cytology during pregnancy--comparison with non-pregnant women and management o... 7258696 - Prenatal and postnatal development of the cervical portion of the spine in the short-fi... 1565396 - Intraoperative amniocentesis and indomethacin treatment in the management of an immatur... 17118436 - Influence of sire and sire breed (gyr versus holstein) on establishment of pregnancy an... 17201976 - The ecology of helicoverpa spp. (lepidoptera: noctuidae) in the riverina region of sout... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Obstetrics and gynecology Volume: 101 ISSN: 0029-7844 ISO Abbreviation: Obstet Gynecol Publication Date: 2003 Apr |
Date Detail:
|
Created Date: 2003-04-08 Completed Date: 2003-04-24 Revised Date: 2009-10-26 |
Medline Journal Info:
|
Nlm Unique ID: 0401101 Medline TA: Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: 722-5 Citation Subset: AIM; IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Göteborg University, Göteborg. erling.ekerhovd@obgyn.gu.se |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortifacient Agents, Nonsteroidal
/
administration & dosage* Abortion, Induced* Administration, Intravaginal Adolescent Adult Alprostadil / administration & dosage*, analogs & derivatives* Cervical Ripening* Female Humans Misoprostol / administration & dosage* Pregnancy Pregnancy Trimester, First Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol; 64318-79-2/gemeprost; 745-65-3/Alprostadil |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Therapeutic equivalence of alendronate 35 milligrams once weekly and 5 milligrams daily in the preve...
Next Document: A randomized clinical trial of prophylaxis for vacuum abortion: 3 versus 7 days of doxycycline.